CareDx, Inc. (CDNA)
47.50
-1.11
(-2.28%)
USD |
NASDAQ |
Aug 24, 16:00
47.51
+0.01
(+0.02%)
After-Hours: 04:53
CareDx EPS Diluted (Quarterly) : 2.071 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.071 |
| March 31, 2026 | 0.0529 |
| December 31, 2025 | -0.0804 |
| September 30, 2025 | 0.0312 |
| June 30, 2025 | -0.1578 |
| March 31, 2025 | -0.1873 |
| December 31, 2024 | 1.506 |
| September 30, 2024 | -0.2011 |
| June 30, 2024 | -0.0886 |
| March 31, 2024 | -0.3847 |
| December 31, 2023 | -2.212 |
| September 30, 2023 | -0.4335 |
| June 30, 2023 | -0.4634 |
| March 31, 2023 | -0.4427 |
| December 31, 2022 | -0.3424 |
| September 30, 2022 | -0.3167 |
| June 30, 2022 | -0.4075 |
| March 31, 2022 | -0.3706 |
| December 31, 2021 | -0.3056 |
| September 30, 2021 | -0.2258 |
| June 30, 2021 | -0.0369 |
| March 31, 2021 | -0.0134 |
| December 31, 2020 | -0.0713 |
| September 30, 2020 | -0.0575 |
| June 30, 2020 | -0.1467 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.136 |
| December 31, 2019 | -0.1125 |
| September 30, 2019 | -0.0428 |
| June 30, 2019 | -0.1862 |
| March 31, 2019 | -0.181 |
| December 31, 2018 | -0.0936 |
| September 30, 2018 | -0.5375 |
| June 30, 2018 | -0.40 |
| March 31, 2018 | -0.30 |
| December 31, 2017 | -1.13 |
| September 30, 2017 | -0.63 |
| June 30, 2017 | -0.19 |
| March 31, 2017 | -0.26 |
| December 31, 2016 | -0.73 |
| September 30, 2016 | -0.26 |
| June 30, 2016 | -0.77 |
| March 31, 2016 | -0.81 |
| December 31, 2015 | -0.40 |
| September 30, 2015 | -0.29 |
| June 30, 2015 | -0.27 |
| March 31, 2015 | -0.19 |
| December 31, 2014 | -0.0004 |
| September 30, 2014 | 0.12 |
| June 30, 2014 | 0.0733 |
| March 31, 2014 | -0.11 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Natera, Inc. | -0.4674 |
| Caris Life Sciences, Inc. | -0.0022 |
| Myriad Genetics, Inc. | -0.4557 |
| BioRestorative Therapies, Inc. | -0.1215 |
| Exagen, Inc. | -0.1323 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 110.64M |
| Revenue (Quarterly) | 131.95M |
| Total Expenses (Quarterly) | 21.31M |
| Enterprise Value | 2.091B |
| Gross Profit Margin (Quarterly) | 73.37% |
| Profit Margin (Quarterly) | 83.85% |
| Earnings Yield | 4.37% |
| Normalized Earnings Yield | 4.451 |